183 related articles for article (PubMed ID: 15066674)
1. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy.
Placidi F; Tombini M; Romigi A; Bianchi L; Izzi F; Sperli F; Mattia D; Cervellino A; Marciani MG
Epilepsy Res; 2004 Jan; 58(1):43-52. PubMed ID: 15066674
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
[TBL] [Abstract][Full Text] [Related]
5. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
6. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
Huang CW; Pai MC; Tsai JJ
Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374
[TBL] [Abstract][Full Text] [Related]
7. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study.
Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI
Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
Abou-Khalil B
Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
Mattia D; Spanedda F; Bassetti MA; Romigi A; Placidi F; Marciani MG
Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
[TBL] [Abstract][Full Text] [Related]
11. Postponing the morning dose of AEDs: effect on the epileptiform EEG activity.
Kipervasser S; Vishne T; Neufeld MY
Acta Neurol Scand; 2012 Jul; 126(1):52-5. PubMed ID: 22320851
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
Ben-Menachem E
Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
[TBL] [Abstract][Full Text] [Related]
14. Identifying the cortical substrates of interictal epileptiform activity in patients with extratemporal epilepsy: An EEG-fMRI sequential analysis and FDG-PET study.
Donaire A; Capdevila A; Carreño M; Setoain X; Rumià J; Aparicio J; Campistol J; Padilla N; Sanmartí F; Vernet O; Pintor L; Boget T; Ortells J; Bargalló N
Epilepsia; 2013 Apr; 54(4):678-90. PubMed ID: 23362864
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
17. Serum concentration/dose ratio of topiramate during pregnancy.
Westin AA; Nakken KO; Johannessen SI; Reimers A; Lillestølen KM; Brodtkorb E
Epilepsia; 2009 Mar; 50(3):480-5. PubMed ID: 19178558
[TBL] [Abstract][Full Text] [Related]
18. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
19. Chronic application of topiramate and carbamazepine differentially affects the EEG and penicillin-induced epileptiform activity in rats.
Aydin-Abidin S; Yildirim M; Abidin İ; Cansu A
Neurol Res; 2012 Apr; 34(3):246-51. PubMed ID: 22449613
[TBL] [Abstract][Full Text] [Related]
20. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
Majkowski J; Neto W; Wapenaar R; Van Oene J
Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
